Applicant, as named in the Orange Book

St Renatus

Next listed expiry: Kovanaze on 2 Apr 2030. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Kovanaze NDA 208032 oxymetazoline hydrochloride; tetracaine hydrochloride	oxymetazoline hydrochloride; tetracaine hydrochloride	2 Apr 2030 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.